Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COATS: Comparison of Antipsychotics in Schizophrenia
NCT00802100Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Dec 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of olanzapine, Perphenazine and aripiprazole in schizophrenia and schizoaffective disorder, sponsored by National Institute of Mental Health. Started Dec 2008; status: completed.
02
Drugs
olanzapinePerphenazinearipiprazole
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00802100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802100.